Related Experiment Video
Updated: Jan 26, 2026

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
Published on: February 5, 2019
Treatment of infant formula with patiromer dose dependently decreases potassium concentration
Neil J Paloian1, Barbara Bowman2, Sharon M Bartosh2
1Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, 600 Highland Ave, Madison, WI, 53792, USA. npaloian@wisc.edu.
Insights
Patiromer, a novel polymer, effectively reduces potassium in infant formula, offering a promising solution for managing hyperkalemia in infants with chronic kidney disease (CKD). This study demonstrates its potential for dietary potassium management.
Area of Science:
- Nephrology
- Pediatric Nutrition
- Pharmaceutical Chemistry
Background:
- Hyperkalemia is a serious risk for infants with chronic kidney disease (CKD).
- Low-potassium infant formulas are available, but further dietary potassium restriction is often needed.
- Patiromer, a calcium-based polymer, is a potential agent to reduce potassium in formulas, but efficacy data were lacking.
Purpose of the Study:
- To evaluate the efficacy of patiromer in reducing potassium levels in infant formulas.
- To assess the impact of varying patiromer doses and treatment durations on formula composition.
- To investigate changes in other key electrolytes (calcium, sodium, magnesium, phosphorus) following patiromer treatment.
Main Methods:
- Patiromer was added at different doses to two standard infant formulas (Similac Advance and Similac PM 60/40).
- Potassium, calcium, sodium, magnesium, and phosphorus levels were measured at baseline and at 30 minutes, 60 minutes, and 24 hours post-administration.
- Dose-dependent effects and time-course of ion exchange were analyzed.
Main Results:
- Patiromer significantly decreased potassium concentrations in both formulas in a dose-dependent manner.
- The most substantial potassium reduction occurred within 30 minutes of treatment.
- Calcium levels increased dose-dependently, as expected, with minor changes observed in magnesium, sodium, and phosphorus.
Conclusions:
- Pre-treatment of infant formula with patiromer effectively lowers potassium levels.
- The ion-exchange process is rapid, with significant effects seen within 30 minutes.
- Patiromer shows promise as a novel therapeutic option for managing hyperkalemia in infants with CKD.
Background:
Hyperkalemia is a potentially life-threatening complication of chronic kidney disease (CKD). Dietary potassium restriction is challenging in infants despite low-potassium formulas. Decreasing potassium in formula using patiromer, a new calcium-based cation exchange polymer may be one option to accomplish this; however, data confirming efficacy is lacking.
Methods:
Varying doses of patiromer were added to prepared Similac Advance and Similac PM 60/40. Measurements of potassium, calcium, sodium, magnesium, and phosphorus were obtained at baseline and at 30 min, 60 min, and 24 h following patiromer administration.
Results:
Following pre-treatment with patiromer, the potassium concentration of both formulas decreased. This effect was mild with the lowest dose but increased in a dose-dependent fashion. Treating for 60 min or 24 h did not yield substantially greater effects than treating for 30 min. Calcium levels increased in both formula groups, mostly in a dose-dependent fashion. Changes in magnesium, sodium, and phosphorus were also seen after patiromer pre-treatment.
Conclusions:
Pre-treatment with patiromer decreases the potassium concentration of infant formula. Calcium levels increased after treatment as expected with the majority of ion exchange occurring in 30 min. Treatment of formula with patiromer shows promise as a unique option for managing hyperkalemia.
Related Concept Videos
Drug Dosing: Infants and Children
Chemical Formulas
The Integrated Rate Law: The Dependence of Concentration on Time
Molecular Compounds: Formulas and Nomenclature
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Ionic Compounds: Formulas and Nomenclature

